A team at The University of Texas MD Anderson Cancer Center in Houston led by original pioneers in immuno-oncology have published a paper in Nature Medicine that discusses an immune-suppressing enzyme that was strongly present in glioblastoma but not in 5 other tumor types the team studied.
As Humira biosimilars enter the market, patient education about biosimilars is crucial to prevent the nocebo effect when patients switch from the reference product, explained…
An Iowa abortion ban is temporarily blocked; Pfizer partners with Flagship Pioneering in drug development deal; South Dakota’s governor calls for action in addressing the…
Researchers summarized the limited available data on human papillomavirus (HPV) vaccine efficiency and immunogenicity in people living with HIV and gave insight into topics for…
A study from Western Australia found that the influenza vaccine has a possible protective effect against hospitalization for respiratory syncytial virus (RSV).
Panelists reached a consensus on statements about chronic cough diagnosis, helping to solidify opinions that can assist in the future creation of assessment guidelines.
After receiving 4.8 mg of survodutide weekly for 46 weeks, more than half of trial participants achieved weight loss of 15% or more.
Although human papillomavirus (HPV) was detected in 40% of pregnant women, only 7.2% of neonates tested positive for HPV.
Researchers conducted a voluntary surveillance program in a Kansas City, Missouri, school district to detect the prevalence of respiratory viruses among students and staff members.
In addition to a fear of cancer recurrence, patients said feeling isolated was also a challenge associated with having ovarian cancer.
A study suggests that strains of ruminococcus (blautia) gnavus (RG) seen in the gut microbiome of patients in active lupus nephritis might be drivers of…
